VTRS(VTRS)
VTRS
Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data
Next report
Nov 5 2026in 29 days
EPS estimate
$0.65
Revenue estimate
$3.80B
EPS beats
9 of last 12
EPS surprise
Each report against the estimate that stood when it landed.
Nov 7 2023Aug 6 2026
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Aug 6 2026 | $0.60 | $0.69 | +14.8% | $3.68B | $3.76B | +2.2% |
| May 7 2026 | $0.50 | $0.59 | +17.5% | $3.36B | $3.52B | +4.8% |
| Feb 26 2026 | $0.53 | $0.57 | +7.1% | $3.53B | $3.70B | +4.8% |
| Nov 6 2025 | $0.62 | $0.67 | +7.9% | $3.62B | $3.76B | +3.8% |
| Aug 7 2025 | $0.56 | $0.62 | +11.5% | $3.47B | $3.58B | +3.3% |
| May 8 2025 | $0.49 | $0.50 | +1.6% | $3.24B | $3.25B | +0.6% |
| Feb 27 2025 | $0.61 | $0.54 | -11.5% | $3.60B | $3.53B | -2.0% |
| Nov 7 2024 | $0.68 | $0.75 | +10.8% | $3.72B | $3.74B | +0.6% |
| Aug 8 2024 | $0.68 | $0.69 | +1.8% | $3.78B | $3.80B | +0.4% |
| May 9 2024 | $0.67 | $0.67 | -0.4% | $3.69B | $3.66B | -0.7% |
| Feb 28 2024 | $0.67 | $0.61 | -9.0% | $3.87B | $3.84B | -0.8% |
| Nov 7 2023 | $0.74 | $0.78 | +5.4% | $3.87B | $3.94B | +1.9% |
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+1.70%
EPS+6.41%
FY2028
Rev+3.11%
EPS+7.33%
FY2029
Rev+3.91%
EPS+0.85%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14.79B | $15.04B | $15.51B | $16.12B | $16.90B |
| Low | $14.78B | $14.88B | $15.20B | $15.94B | $16.71B |
| High | $14.81B | $15.39B | $15.84B | $16.36B | $17.16B |
| EBITDA Avg | $6.57B | $6.40B | $6.30B | $6.21B | $6.27B |
| Low | $6.49B | $6.29B | $4.90B | $6.15B | $6.21B |
| High | $6.61B | $6.58B | $8.11B | $6.29B | $6.36B |
| EBIT Avg | $4.25B | $4.46B | $4.66B | $4.81B | $5.06B |
| Low | $4.17B | $4.35B | $3.26B | $4.75B | $5.00B |
| High | $4.29B | $4.65B | $6.47B | $4.90B | $5.15B |
| Net Income Avg | $2.95B | $3.12B | $3.28B | $3.40B | $3.59B |
| Low | $2.89B | $3.03B | $2.17B | $3.35B | $3.54B |
| High | $2.98B | $3.26B | $4.72B | $3.46B | $3.67B |
| EPS Avg | $2.52 | $2.68 | $2.88 | $2.90 | $3.07 |
| Low | $2.47 | $2.59 | $1.85 | $2.86 | $3.03 |
| High | $2.55 | $2.79 | $4.03 | $2.96 | $3.13 |
| Analysts (Rev / EPS) | 7 / 7 | 7 / 7 | 6 / 3 | 4 / 1 | 3 / 1 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $3.72B | $3.55B | $3.78B | $3.89B | $3.83B |
| Low | $3.69B | $3.48B | $3.70B | $3.81B | $3.75B |
| High | $3.75B | $3.60B | $3.83B | $3.95B | $3.88B |
| EBITDA Avg | $1.54B | $1.55B | $1.66B | $1.63B | $1.56B |
| Low | $1.47B | $1.53B | $1.64B | $1.61B | $1.54B |
| High | $1.60B | $1.57B | $1.68B | $1.65B | $1.58B |
| EBIT Avg | $989M | $1.03B | $1.16B | $1.15B | $1.10B |
| Low | $917M | $1.00B | $1.13B | $1.12B | $1.07B |
| High | $1.05B | $1.05B | $1.18B | $1.17B | $1.12B |
| Net Income Avg | $690M | $721M | $824M | $815M | $777M |
| Low | $632M | $702M | $802M | $794M | $756M |
| High | $736M | $735M | $840M | $831M | $792M |
| EPS Avg | $0.59 | $0.62 | $0.71 | $0.70 | $0.67 |
| Low | $0.54 | $0.60 | $0.69 | $0.68 | $0.65 |
| High | $0.63 | $0.63 | $0.72 | $0.71 | $0.68 |
| Analysts (Rev / EPS) | 6 / 7 | 3 / 2 | 3 / 2 | 3 / 2 | 3 / 5 |
AI Earnings SummaryQ2 2026
Checking for summary...
Explore More
Healthcare Stocks
More Healthcare stocks
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers
